|
EpiCast Report: Acute Coronary Syndrome - Epidemiology Forecast to 2025 |
Aug 8 2016 |
79 |
Global |
$3,995.00 |
|
|
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2016 |
Aug 4 2016 |
133 |
Global |
$1,500.00 |
|
|
Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
60 |
Global |
$2,500.00 |
|
|
Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
586 |
Global |
$2,500.00 |
|
|
Unstable Angina Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
144 |
Global |
$2,500.00 |
|
|
Eisenmenger Syndrome Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
43 |
Global |
$2,500.00 |
|
|
Low-Grade Astrocytoma Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
40 |
Global |
$2,500.00 |
|
|
Vascular Calcification Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
48 |
Global |
$2,500.00 |
|
|
Atrial Septal Defect Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
35 |
Global |
$2,500.00 |
|
|
Ocular Melanoma Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
138 |
Global |
$2,500.00 |
|
|
Stable Angina Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
114 |
Global |
$2,500.00 |
|
|
Arterial Thrombosis Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
56 |
Global |
$2,500.00 |
|
|
Low-Grade Glioma Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
107 |
Global |
$2,500.00 |
|
|
Telangiectasis Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
42 |
Global |
$2,500.00 |
|
|
Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
235 |
Global |
$2,500.00 |
|
|
Critical Limb Ischemia Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
119 |
Global |
$2,500.00 |
|
|
Pheochromocytoma Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
70 |
Global |
$2,500.00 |
|
|
Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
295 |
Global |
$2,500.00 |
|
|
Metastatic Hepatocellular Carcinoma (HCC) Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
123 |
Global |
$2,500.00 |
|
|
Arterial Calcification Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
45 |
Global |
$2,500.00 |
|
|
Metastatic Prostate Cancer Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
315 |
Global |
$2,500.00 |
|
|
Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
314 |
Global |
$2,500.00 |
|
|
Renal Cell Carcinoma Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
1153 |
Global |
$2,500.00 |
|
|
Coronary Stenosis Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
68 |
Global |
$2,500.00 |
|
|
Vasospastic Angina Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
34 |
Global |
$2,500.00 |
|
|
Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
76 |
Global |
$2,500.00 |
|
|
Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
384 |
Global |
$2,500.00 |
|
|
Aortic Valve Stenosis Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
62 |
Global |
$2,500.00 |
|
|
Thrombophlebitis Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
42 |
Global |
$2,500.00 |
|
|
Intermittent Claudication Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
82 |
Global |
$2,500.00 |
|
